Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10788140 | 0.81 | SMN1; SMN2 (0.32) | TSHRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11004964 | 0.81 | SMN1; SMN2 (0.32) | TSHRMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL10019517 | 0.79 | MGAM (0.37) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL31221642 | 0.76 | KMT2A (0.39) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL31221644 | 0.73 | TSHR (0.36) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL1480200 | 0.67 | TSHR (0.42) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL15455290 | 0.67 | CA14 (0.36) | TSHR | |
| SCHEMBL3410284 | 0.66 | TSHR (0.46) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL6442162 | 0.66 | TSHR (0.46) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL3237660 | 0.66 | KMT2A (0.48) | MGAMGAASIMGAM2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0493813-A1 | 2,5-Dioxopiperazine compound and processes for preparation thereof | Ajinomoto Co., Inc. (JP) | 1992-07-08 | — | — | EP | disclosed |